Regarding REMAP-CAP, I'm assuming that the trial would have patients on a combination of DMX-200 (Propagermanium) + Irbesartan, not DMX-200 alone?? Wouldn't make sense otherwise.
Regarding REMAP-CAP, I'm assuming that the trial would have...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $184.1M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 33.5¢ | 33.5¢ | $35.99K | 107.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 199803 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 185750 | 4 |
View Market Depth
| Last trade - 10.02am 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
34.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 33.5¢ | 34.0¢ | 33.5¢ | 12501 | ||
| Last updated 10.18am 16/05/2024 ? | |||||
| DXB (ASX) Chart |